The way forward imo is to start a trial in Britian and or EU that is confirmational based on previous data from trials in usa. But most importantly the cells used have to come from new advanced cheaper manufacturing methods that need to be employed to bring these therapies to the masses.
Clarity in manufacturing has been an issue holding back this sector IMO..good luck believers
2023 Next Steps, page-114
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.05 |
Change
0.075(7.73%) |
Mkt cap ! $1.107B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.06 | 99.0¢ | $3.292M | 3.213M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 31189 | $1.04 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.05 | 111652 | 19 |
View Market Depth
| Last trade - 12.49pm 04/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |